Peripartum Cardiomyopathy: Pathophysiological Mechanisms, Clinical Spectrum, and Long-Term Outcomes
Clinical Cardiology and Cardiovascular Interventions · 07.05.2026 · 09 (07) · 01-18
DOI: 10.31579/2641-0419/560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology and Cardiovascular Interventions, online erschienen am 07.05.2026. Verfasst von Abdülmelik Birgün und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Peripartum cardiomyopathy (PPCM) is an idiopathic systolic heart failure syndrome occurring in late pregnancy or the early postpartum period in the absence of pre-existing structural heart disease. Once considered a rare obstetric complication, PPCM is now recognized as a heterogeneous cardiomyopathy arising from the interplay of pregnancy-related vascular stress and underlying myocardial vulnerability. This narrative review summarizes current evidence on epidemiology, pathophysiology, clinical presentation, imaging, management, and long-term outcomes. Contemporary mechanistic models emphasize angiogenic imbalance, prolactin cleavage, oxidative stress, inflammation, and genetic susceptibility as central contributors to myocardial dysfunction. Clinical presentation ranges from mild heart failure symptoms to cardiogenic shock, ventricular arrhythmias, and thromboembolism. Echocardiography remains the diagnostic cornerstone, while strain imaging and cardiac magnetic resonance provide additional phenotypic and prognostic insight. Recovery is highly variable; although many women demonstrate substantial improvement within 6–12 months, a significant proportion develop persistent left ventricular dysfunction with long-term implications. Baseline ventricular function and early recovery trajectory are key determinants of outcome. Management requires pregnancy-adapted heart failure therapy, structured follow-up, and multidisciplinary cardio-obstetric care. Future efforts should prioritize phenotype-driven strategies, optimized risk stratification, and large collaborative registries to refine precision management in PPCM.
Zitieren
APA
Birgün, A., Bekar, L., Kalçık, M., Sarıhan, A., Şahin, M. M., Çelik, Ö. B., Çelik, M. C., Yılmaz, M. M., Yetim, M., & Karavelioğlu, Y. (2026). Peripartum Cardiomyopathy: Pathophysiological Mechanisms, Clinical Spectrum, and Long-Term Outcomes. Clinical Cardiology and Cardiovascular Interventions, 09(07), 01-18. https://doi.org/10.31579/2641-0419/560
Vancouver
Birgün A, Bekar L, Kalçık M, Sarıhan A, Şahin MM, Çelik ÖB, et al. Peripartum Cardiomyopathy: Pathophysiological Mechanisms, Clinical Spectrum, and Long-Term Outcomes. Clinical Cardiology and Cardiovascular Interventions. 2026;09(07):01-18. doi:10.31579/2641-0419/560
BibTeX
@article{Birgn2026,
author = {Birgün, Abdülmelik and Bekar, Lütfü and Kalçık, Macit and Sarıhan, Abdullah and Şahin, Mehmet Murat and Çelik, Ömer Burak and Çelik, Muhammet Cihat and Yılmaz, Mehmet Mustafa and Yetim, Mucahit and Karavelioğlu, Yusuf},
title = {Peripartum Cardiomyopathy: Pathophysiological Mechanisms, Clinical Spectrum, and Long-Term Outcomes},
journal = {Clinical Cardiology and Cardiovascular Interventions},
year = {2026},
volume = {09},
number = {07},
pages = {01--18},
doi = {10.31579/2641-0419/560}
}
EUVIMED